|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.35 SEK | +3.14% |
|
+12.84% | -29.07% |
| 06-09 | Orexo AB Announces Appointment of Raheleh Nassaji as Senior Vice President Business Development | CI |
| 06-09 | Orexo appoints new Head of Business Development | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 76.92M | - | - | |||
| 294B | |||||
| 67.08B | |||||
| 7.84B | |||||
| 4.54B | |||||
| 3.8B |
- Stock Market
- Stocks
- ORX Stock
- Charts Orexo AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
